Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OGI - CA68617J1003 - Common Stock

1.61 USD
0 (0%)
Last: 11/26/2025, 8:00:02 PM
1.7 USD
+0.09 (+5.59%)
After Hours: 11/26/2025, 8:00:02 PM

OGI Key Statistics, Chart & Performance

Key Statistics
Market Cap216.27M
Revenue(TTM)223.82M
Net Income(TTM)7.77M
Shares134.33M
Float90.75M
52 Week High2.08
52 Week Low0.85
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0
PEN/A
Fwd PE1497.08
Earnings (Next)12-16 2025-12-16/amc
IPO2011-11-24
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


OGI short term performance overview.The bars show the price performance of OGI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

OGI long term performance overview.The bars show the price performance of OGI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of OGI is 1.61 USD. In the past month the price increased by 0.63%. In the past year, price increased by 6.62%.

ORGANIGRAM GLOBAL INC / OGI Daily stock chart

OGI Latest News, Press Relases and Analysis

OGI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 50.22 1.05T
JNJ JOHNSON & JOHNSON 20 499.88B
MRK MERCK & CO. INC. 11.88 261.34B
PFE PFIZER INC 8.03 146.18B
BMY BRISTOL-MYERS SQUIBB CO 7.51 100.25B
ZTS ZOETIS INC 20.14 56.59B
RPRX ROYALTY PHARMA PLC- CL A 9.69 23.23B
VTRS VIATRIS INC 4.57 12.40B
ELAN ELANCO ANIMAL HEALTH INC 24.28 11.58B
CORT CORCEPT THERAPEUTICS INC 90.68 8.39B
AXSM AXSOME THERAPEUTICS INC N/A 7.53B
BLTE BELITE BIO INC - ADR N/A 4.52B

About OGI

Company Profile

OGI logo image Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

Company Info

ORGANIGRAM GLOBAL INC

35A English Dr

Moncton NEW BRUNSWICK E1E 3X3 CA

CEO: Greg Engel

Employees: 1178

OGI Company Website

OGI Investor Relations

Phone: 15063841571

ORGANIGRAM GLOBAL INC / OGI FAQ

Can you describe the business of ORGANIGRAM GLOBAL INC?

Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.


What is the stock price of ORGANIGRAM GLOBAL INC today?

The current stock price of OGI is 1.61 USD.


Does OGI stock pay dividends?

OGI does not pay a dividend.


How is the ChartMill rating for ORGANIGRAM GLOBAL INC?

OGI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of OGI stock?

ORGANIGRAM GLOBAL INC (OGI) has a market capitalization of 216.27M USD. This makes OGI a Micro Cap stock.


Can you provide the ownership details for OGI stock?

You can find the ownership structure of ORGANIGRAM GLOBAL INC (OGI) on the Ownership tab.


OGI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to OGI. When comparing the yearly performance of all stocks, OGI turns out to be only a medium performer in the overall market: it outperformed 44.84% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OGI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to OGI. Both the profitability and financial health of OGI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OGI Financial Highlights


Industry RankSector Rank
PM (TTM) 3.47%
ROA 1.38%
ROE 2.02%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%-253.85%
Sales Q2Q%72.41%
EPS 1Y (TTM)98.88%
Revenue 1Y (TTM)38.86%

OGI Forecast & Estimates

8 analysts have analysed OGI and the average price target is 2.19 USD. This implies a price increase of 36.01% is expected in the next year compared to the current price of 1.61.

For the next year, analysts expect an EPS growth of 119.5% and a revenue growth 57.11% for OGI


Analysts
Analysts77.5
Price Target2.19 (36.02%)
EPS Next Y119.5%
Revenue Next Year57.11%

OGI Ownership

Ownership
Inst Owners6.05%
Ins Owners2.53%
Short Float %5.46%
Short Ratio7.46